KALVISTA PHARMACEUTICALS INC
KALVISTA PHARMACEUTICALS INC logo
KALV

KALVISTA PHARMACEUTICALS INC (KALV)

$5.091.55%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$5.0
Day's Range
$5.26
$4.12
52-Week Range
$17.35
1 month return4.5%
3 month return67.48%
1 year return61.41%
5 year return47.14%

Company Information

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME). KalVista is developing KVD900 as an oral on-demand therapy for acute HAE attacks, which completed a Phase 2 efficacy trial in February 2021, demonstrating statistical and clinical significance across all endpoints. KVD824 is in development for prophylactic treatment of HAE with a Phase 2 clinical trial expected to initiate in the second quarter of 2021. In addition, KalVista's oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve the treatment of HAE for patients. In DME, an intravitreally administered plasma kallikrein inhibitor, called KVD001, has completed a Phase 2 clinical trial.
OrganizationKALVISTA PHARMACEUTICALS INC
Employees105
CEOMr. Thomas Andrew Crockett M.B.A.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for KALVISTA PHARMACEUTICALS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 328.88%

Current

$5.09

Target

$21.83

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
11
11
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
125.3M
Book Value
$6.7
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.05
PEG Ratio
0.0
Wall Street Target Price
21.83

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.8
Enterprise Value
-705117
Enterprise Value/Revenue
76.33
Enterprise Value/Ebitda
0.01

Technicals

Beta
1.18
50 Day MA
6.13
200 Day MA
11.35

Institutional Holdings

Deep Track Capital, LP

7.41%

TANG CAPITAL MANAGEMENT LLC

7.32%

Suvretta Capital Management, LLC

6.94%

BlackRock Inc

6.94%

Great Point Partners LLC

6.31%

Vivo Capital, LLC

6.23%

Discover more

Frequently Asked Questions

What is KALVISTA PHARMACEUTICALS INC share price today?

Can Indians buy KALVISTA PHARMACEUTICALS INC shares?

How can I buy KALVISTA PHARMACEUTICALS INC shares from India?

Can Fractional shares of KALVISTA PHARMACEUTICALS INC be purchased?

What are the documents required to start investing in KALVISTA PHARMACEUTICALS INC stocks?

What are today’s High and Low prices of KALVISTA PHARMACEUTICALS INC?

What are today’s traded volumes of KALVISTA PHARMACEUTICALS INC?

What is today’s market capitalisation of KALVISTA PHARMACEUTICALS INC?

What is the 52 Week High and Low Range of KALVISTA PHARMACEUTICALS INC?

How much percentage KALVISTA PHARMACEUTICALS INC is down from its 52 Week High?

How much percentage KALVISTA PHARMACEUTICALS INC is up from its 52 Week low?

What are the historical returns of KALVISTA PHARMACEUTICALS INC?

Who is the Chief Executive Officer (CEO) of KALVISTA PHARMACEUTICALS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*